Drug Approval | September 30, 2023
Lupin Receives EIR from U.S. FDA for its Nagpur Unit-1 manufacturing facility
The U.S. FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
The U.S. FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
Capital raise to accelerate product and technology development and support expansion efforts to reshape communications to HCPs across the globe
The first phase of the hospital with 225 beds built over 1.75 lakh square feet will be commissioned in the next 12 months
Minister was briefed on the nationwide dengue situation
Education on Inhalation Therapy & Conducting Nationwide Awareness Camps, Alkem Breathe Initiative Addresses the Alarming Increase in Respiratory Diseases in India
‘Sanjeevani’ aims to raise awareness and encourage conversations around the silent cancer epidemic
30 beneficiaries avail of services per minute
National Health Authority (NHA) to host the two-day Arogya Manthan event in New Delhi
Dr. Jitendra Singh inaugurates 300 LPM capacity Oxygen Plant, Day Care Chemotherapy Unit affiliated to Tata Memorial Hospital & Maternal ICU at GMC Kathua
The campus in Genome Valley will provide services in discovery chemistry & discovery biology, safety toxicology, bioanalytical services and formulation development to global pharmaceutical companies
Subscribe To Our Newsletter & Stay Updated
